logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
R

Raffaele Califano

University of Manchester
H指数:43
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Seasonal variations in overall survival and vitamin D status in a UK pan-cancer cohort receiving checkpoint inhibitors

英国泛癌种队列接受免疫检查点抑制剂治疗患者的总体生存率及维生素D状态的季节性变化

Cancer Immunology Immunotherapy
IF5.1
2026-09-290
OAAI
Oliver Kennedy; Nadia Ali; Rebecca Lee; Safwaan Adam; Fiona Helen Blackhall; Raffaele Califano; Tim Cooksley; Laura Cove-Smith; Victoria Foy; Avinash Gupta; Robert Metcalf; Phillip J. Monaghan; Manon Rhys Pillai; Patricio Serra-Bellver; Yvonne Summers; Tom Waddell; Paul Lorigan
Patient-Relevant Outcomes From the Phase III MARIPOSA-2 Trial: Amivantamab-Chemotherapy Versus Chemotherapy in EGFR-Mutant Advanced Non-Small-Cell Lung Cancer Following Disease Progression on Osimertinib
Clinical Lung Cancer
IF3.3
2025-12-200
PRE
Pascale Tomasini; Oscar Juan-Vidal; Raffaele Califano; Chien-Chung Lin; Pauline Hulo; Christophe Dooms; Jian Fang; Ana Blasco; Dariusz Kowalski; Jorge Salinas; Govind Babu; Tho Lye Mun; Alessandra Bearz; Veerle Surmont; Clarissa Baldotto; Richu Sharma; Oscar Arrieta; Katarzyna Stencel; Cynthia Card; Alona Zer
EORTC 1417 - REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancer

EORTC 1417 - REACTION：一项关于依托泊苷联合顺铂/卡铂，并联合或不联合帕博利珠单抗治疗初治广泛期小细胞肺癌的II期研究

European Journal of Cancer
IF7.1
2025-10-300
PRE
Jessica Menis; Laurent Greiller; Pierre Demontrond; Isabelle Monnet; Silvia Novello; Lorenzo Livi; Robin Young; Chantal Decroisette; Nicolas Cloarec; Gilles Robinet; Roland Schott; Jerome Fayette; Giuseppe Luigi Banna; Filippo De Marinis; Raffaele Califano; Boris Duchemann; Andrea Luciani; Ida Colantonio; Beatrice Fournier; Yassin Pretzenbacher; Caroline Caramella; Mario Silva; Thierry Berghmans; Anne-Marie Dingemans; Paolo Bironzo; Jonathan Tugwood; Cong Zhou; Steven Hill; Kieran Bradbury; Karen Morris; Elaine Kilgour; Caroline Dive; Fiona Blackhall; Benjamin Besse
Real-world outcomes of second-line carboplatin plus pemetrexed after first-line osimertinib in EGFR-mutant advanced NSCLC: An international multicentre cohort study

EGFR突变晚期非小细胞肺癌患者在接受一线奥希替尼治疗后，接受卡铂联合培美曲塞二线治疗的实际疗效：一项国际多中心队列研究

Lung Cancer
IF4.4
2025-10-160
PRE
Igor Gomez-Randulfe; Federico Monaca; Ornella Cantale; Maria Lucia Reale; Loredana Mrak; Lodovica Zullo; Sofia Silva Diaz; Marta Zaragoza Bueno; Marya Alejandra Maridueña Moreno; Charlotte Davis; Samantha Cox; Daniel Lee; Riyaz Shah; Tom Geldart; Javier Baena; Jose Carlos Benitez; M.A. Rosario Garcia Campelo; Jordi Remon; David Planchard; Domenico Galetta; Marcello Tiseo; Diego Cortinovis; Giulio Metro; Emilio Bria; Francesco Passiglia; Silvia Novello; Raffaele Califano
Impact of platinum-based chemotherapy and CTLA-4 inhibition on acquired resistance to first-line anti-PD-1/PD-L1 agents in non-small cell lung cancer: a systematic review and reconstructed individual patient data analysis

铂类化疗和CTLA-4抑制对非小细胞肺癌中一线抗PD-1/PD-L1药物获得性耐药的影响：一项系统综述和重构的个体患者数据分析

eClinicalMedicine
IF10
2025-09-020
PREAI
Sara Oresti; Fabio Salomone; Antonio Nuccio; Francesca Rita Ogliari; Silvia Teresa Riva; Ludovica Mollica; Alessandra Bulotta; Maria Grazia Viganò; Francesco Maria Venanzi; Francesco Passaretti; Ludovica Papotto; Anna Di Lello; Michele Ferrara; Giorgia Foggetti; Giuseppe Damiano; Alberto Servetto; Raffaele Califano; Massimo Di Maio; Biagio Ricciuti; Alessio Cortellini; Martin Reck; Michela Cinquini; Valter Torri; Giuseppe Viscardi; Roberto Ferrara
Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC

携带EGFR突变型晚期非小细胞肺癌患者使用amivantamab-lazertinib的总体生存率

NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2025-09-019
PRE
Yang, James Chih-Hsin; Lu, Shun; Hayashi, Hidetoshi; Felip, Enriqueta; Spira, Alexander I.; Girard, Nicolas; Kim, Yu Jung; Lee, Se-Hoon; Ostapenko, Yurii; Danchaivijitr, Pongwut; Liu, Baogang; Alip, Adlinda; Korbenfeld, Ernesto; Mourao Dias, Josiane; Besse, Benjamin; Passaro, Antonio; Lee, Ki-Hyeong; Xiong, Hailin; How, Soon-Hin; Cheng, Ying; Chang, Gee-Chen; Yoshioka, Hiroshige; Thomas, Michael; Nguyen, Danny; Ou, Sai-Hong Ignatius; Mukhedkar, Sanjay; Prabhash, Kumar; D'Arcangelo, Manolo; Alatorre-Alexander, Jorge; Vazquez Limon, Juan Carlos; Alves, Sara; Stroyakovskiy, Daniil; Peregudova, Marina; Sendur, Mehmet Ali Nahit; Yazici, Ozan; Califano, Raffaele; Gutierrez Calderon, Vanesa; de Marinis, Filippo; Kim, Sang-We; Gadgeel, Shirish M.; Owen, Scott; Xie, John; Sun, Tao; Mehta, Jaydeep; Venkatasubramanian, Raja; Ennis, Mariah; Fennema, Elizabeth; Daksh, Mahesh; Roshak, Amy; Man, Julie; Knoblauch, Roland E.; Bauml, Joshua M.; Baig, Mahadi; Shah, Sujay; Sethi, Seema; Cho, Byoung Chul
Brief Report: Post Hoc Validation of Platinum Ineligibility in NSCLC From the Phase III IPSOS Study

简要报告：IPSOS III期研究中非小细胞肺癌铂类不适用性的事后验证

Journal of Thoracic Oncology
IF20.8
2025-07-220
PRE
Solange Peters; Christian Schulz; Martin Reck; Kumar Prabhash; Dariusz Kowalski; Aleksandra Szczesna; Baohui Han; Achim Rittmeyer; Toby Talbot; David Vicente; Raffaele Califano; Diego Cortinovis; Anh Tuan Le; Dingzhi Huang; Geoffrey Liu; Federico Cappuzzo; Jessica Reyes Contreras; Ramon Palmero; Milena Perez Mak; Sanjay Popat; Youyou Hu; Stefanie Morris; Minu K. Srivastava; Monika Kaul; Vilma Graupner; Barbara Gitlitz; Siow Ming Lee
Constitutive inflammation and epithelial-mesenchymal transition dictate sensitivity to nivolumab in CONFIRM: a placebo-controlled, randomised phase III trial

结构性炎症和上皮间质转化决定了对nivolumab的敏感性: 一项安慰剂对照的随机III期试验

Nature Communications
IF15.7
2025-07-210
OA
Dean A. Fennell; Kayleigh Hill; Min Zhang; Charlotte Poile; Sean Ewings; Essa Y. Baitei; Joanna Dzialo; Nada Nusrat; Jan Rogel; Daniel Faulkner; Christian Ottensmeier; Raffaele Califano; Gerard G. Hanna; Sarah Danson; Nicola Steele; Mavis Nye; Lucy Johnson; Kim Mallard; Joanne Lord; Calley Middleton; Peter Szlosarek; Sam Chan; Liz Darlison; Peter Wells-Jordan; Cathy Richards; James Harber; Aleksandra Bzura; Jake Spicer; Catrin Pritchard; Tamihiro Kamata; Jens C. Hahne; Maymun Jama; Edward J. Hollox; Jason F. Lester; Jin-Li Luo; Zisen Zhou; Hongji Yang; Huiyu Zhou; Astero Klampatsa; Gareth O. Griffiths
Consolidation thoracic radiotherapy after chemoimmunotherapy in ES-SCLC: A multicentric retrospective analysis

化疗免疫治疗后的小细胞肺癌的巩固性胸放射治疗：一项多中心回顾性分析

European Journal of Cancer
IF7.1
2025-06-250
PRE
Federico Monaca; Igor Gomez-Randulfe; Gerard Walls; Ornella Cantale; Ana Parreira; Sara Polidori; Mariantonietta Di Salvatore; Vito Longo; Domenico Galetta; Emanuele Vita; Antonella Martino; Maria Antonietta Gambacorta; Luca Boldrini; Yvonne Summers; Giampaolo Tortora; Fiona Blackhall; Silvia Novello; Clara Chan; Emilio Bria; Corinne Faivre-Finn; Raffaele Califano
First-Line Chemo-Immunotherapy in SCLC: Outcomes of a Binational Real-World Study

SCLC的一线化学免疫疗法: 一项两国现实世界研究的结果

JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2025-01-010
OA
Moliner, Laura; Zellweger, Nuria; Schmid, Sabine; Bertschinger, Martina; Waibel, Christine; Cerciello, Ferdinando; Froesch, Patrizia; Mark, Michael; Bettini, Adrienne; Blum, Veronika; Holer, Lisa; Hayoz, Stefanie; Fruh, Martin; Ahmed, Samreen; Haeuptle, Pirmin; Bhagani, Shradha; Steele, Nicola; Gray, Hannah-Leigh; Robinson, Stephen D.; Davidson, Michael; Cox, Samantha; Khalid, Taha; Geldart, Tom R.; Nolan, Luke; Scott, Deborah C.; Hennah, Lindsay; Newsom-Davis, Tom; Rathbone, Emma; Handforth, Catherine; Denton, Arshi; Merchant, Shairoz; Blackhall, Fiona; Mauti, Laetitia A.; Califano, Raffaele; Rothschild, Sacha I.
Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC

Amivantamab联合Lazertinib治疗先前未经治疗的EGFR突变的晚期NSCLC

NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2024-10-2425
PRE
Cho, Byoung C.; Lu, Shun; Felip, Enriqueta; Spira, Alexander I.; Girard, Nicolas; Lee, Jong-Seok; Lee, Se-Hoon; Ostapenko, Yurii; Danchaivijitr, Pongwut; Liu, Baogang; Alip, Adlinda; Korbenfeld, Ernesto; Mourao Dias, Josiane; Besse, Benjamin; Lee, Ki-Hyeong; Xiong, Hailin; How, Soon-Hin; Cheng, Ying; Chang, Gee-Chen; Yoshioka, Hiroshige; Yang, James C. -H.; Thomas, Michael; Nguyen, Danny; Ou, Sai-Hong I.; Mukhedkar, Sanjay; Prabhash, Kumar; D'Arcangelo, Manolo; Alatorre-Alexander, Jorge; Vazquez Limon, Juan C.; Alves, Sara; Stroyakovskiy, Daniil; Peregudova, Marina; Sendur, Mehmet A. N.; Yazici, Ozan; Califano, Raffaele; Gutierrez Calderon, Vanesa; de Marinis, Filippo; Passaro, Antonio; Kim, Sang-We; Gadgeel, Shirish M.; Xie, John; Sun, Tao; Martinez, Melissa; Ennis, Mariah; Fennema, Elizabeth; Daksh, Mahesh; Millington, Dawn; Leconte, Isabelle; Iwasawa, Ryota; Lorenzini, Patricia; Baig, Mahadi; Shah, Sujay; Bauml, Joshua M.; Shreeve, S. Martin; Sethi, Seema; Knoblauch, Roland E.; Hayashi, Hidetoshi
Efficacy of carboplatin-etoposide rechallenge after first-line chemo-immunotherapy in ES-SCLC: an international multicentric analysis
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2024-09-190
OAAI
Gomez-Randulfe, Igor; Diaz, Sofia Silva; Escriu, Carles; Mohammed, Saara; Shah, Riyaz; Fuentes, Javier David Benitez; Cox, Samantha; Monaca, Federico; Bria, Emilio; Garcia-Campelo, Maria Rosario; Crook, Benjamin; Talbot, Toby; Leporati, Rita; Balachandran, Kirsty; Newsom-Davis, Tom; Hughes, Sarah; Cove-Smith, Laura; Taylor, Paul; Blackhall, Fiona; Califano, Raffaele
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA

Amivantamab联合lazertinib与osimertinib治疗具有高危疾病生物标志物的一线EGFR突变晚期非小细胞肺癌: 来自MARIPOSA的二次分析

ANNALS OF ONCOLOGY
IF65.4
2024-09-015
OAAI
Felip, E.; Cho, B. C.; Gutierrez, V; Alip, A.; Besse, B.; Lu, S.; Spira, A. I.; Girard, N.; Califano, R.; Gadgeel, S. M.; Yang, J. C-H.; Yamamoto, S.; Azuma, K.; Kim, Y. J.; Lee, K. -H.; Danchaivijitr, P.; Ferreira, C. G.; Cheng, Y.; Sendur, M. A. N.; Chang, G. -C.; Wang, C. -C.; Prabhash, K.; Shinno, Y.; Stroyakovskiy, D.; Paz-Ares, L.; Rodriguez-Cid, J. R.; Martin, C.; Campelo, M. R. G.; Hayashi, H.; Nguyen, D.; Tomasini, P.; Gottfried, M.; Dooms, C.; Passaro, A.; Schuler, M.; Gelatti, A. C. Z.; Owen, S.; Perdrizet, K.; Ou, S. -H. I.; Curtin, J. C.; Zhang, J.; Gormley, M.; Sun, T.; Panchal, A.; Ennis, M.; Fennema, E.; Bauml, J. M.; Daksh, M.; Sethi, S.; Lee, S. -H.
Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial

胸膜间皮瘤 (MARS 2) 的扩大胸膜切除术和化学疗法与单纯化学疗法的比较: 一项3期随机对照试验

LANCET RESPIRATORY MEDICINE
IF32.8
2024-06-0121
OAAI
Lim, Eric; Waller, David; Lau, Kelvin; Steele, Jeremy; Pope, Anthony; Ali, Clinton; Bilancia, Rocco; Keni, Manjusha; Popat, Sanjay; O'Brien, Mary; Tokaca, Nadza; Maskell, Nick; Stadon, Louise; Fennell, Dean; Nelson, Louise; Edwards, John; Tenconi, Sara; Socci, Laura; Rintoul, Robert C.; Wood, Kelly; Stone, Amanda; Muthukumar, Dakshinamoorthy; Ingle, Charlotte; Taylor, Paul; Cove-Smith, Laura; Califano, Raffaele; Summers, Yvonne; Tasigiannopoulos, Zacharias; Bille, Andrea; Shah, Riyaz; Fuller, Elizabeth; Macnair, Andrew; Shamash, Jonathan; Mansy, Talal; Milton, Richard; Koh, Pek; Ionescu, Andreea Alina; Treece, Sarah; Roy, Amy; Middleton, Gary; Kirk, Alan; Harris, Rosie A.; Ashton, Kate; Warnes, Barbara; Bridgeman, Emma; Joyce, Katherine; Mills, Nicola; Elliott, Daisy; Farrar, Nicola; Stokes, Elizabeth; Hughes, Vikki; Nicholson, Andrew G.; Rogers, Chris A.

研究方向

暂未获取到该数据
F
Fiona Blackhall
H 指数:89论文数:676被引数:4.0万
E
Enriqueta Felip
H 指数:129论文数:1,499被引数:11.1万
S
Sanjay Popat
H 指数:65论文数:804被引数:3.0万
F
Federico Cappuzzo
H 指数:88论文数:826被引数:4.8万
B
Benjamin Besse
H 指数:100论文数:1,844被引数:5.5万
C
Corinne Faivre‐Finn
H 指数:77论文数:919被引数:3.1万
F
Filippo de Marinis
H 指数:79论文数:726被引数:4.6万
A
Alexander I. Spira
H 指数:67论文数:943被引数:2.8万
J
James Chih‐Hsin Yang
H 指数:141论文数:1,223被引数:10.9万
S
Silvia Novello
H 指数:87论文数:1,020被引数:4.8万